InvestorsHub Logo
Followers 46
Posts 6369
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Thursday, 03/30/2023 7:51:45 AM

Thursday, March 30, 2023 7:51:45 AM

Post# of 470624

“It is encouraging that the patients’ clinical symptoms consistently improved longitudinally over time during the extension phase under active ANAVEX®2-73 treatment,” said Christopher U Missling, PhD, President & CEO of Anavex. “This data suggests ANAVEX®2-73’s potential capability to slow and potentially reverse the life altering symptoms of Parkinson’s disease, an urgent unmet global need.”



I really think "potentially reverse" is a very strong statement from TGD.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News